Our newest article is a result of an interview by Helene Quie to Bassil Akra, AKRA TEAM’s CEO, on the subject of Clinical Evaluations.

Our newest article is a result of an interview by Helene Quie to Søren Underbjerg, Qmed Consulting’s Team Lead for Clinical Development and Market Access, on “The Use Scientific Surveys as a Method to Collect Medical Device Clinical Evidence”.

The transition period for the United Kingdom to leave the European Union is coming to an end on 31 December 2020. After the deadline UK will be considered a third country if no deal is made. This article explains what to expect when bringing your medical device to the UK market….

In Switzerland, just as elsewhere, ‘Europe’ and immigration are closely connected topics. The right wing political party is very vocal in its campaigning to reduce the numbers of foreign workers and to restrict the movement of foreigners across the border….

Important new MDCG guidelines are released from the European Commission. These are importance guidance documents for all of us working within developing and selling medical devices…

Several guidance’s, posts, webinars have been published addressing what evidence collection due to the COVID-19 pandemic, and with this Newsletter we are publishing where to find the different national guidelines and recommendations. Additionally, the MDR Amendment allow us to reconsider our strategies and potential scenarios. In this article…

The pandemic COVID-19 has resulted in various restrictions to countries around the globe. It has affected the ability of notified bodies to conduct mandatory on-site audits under the medical device legislation. The World Health Organization has published guidance on temporary extraordinary measures, which are related to medical devices, Notified Body audits during times of COVID-19. It allows continued availability of safe medical devices to the market and…

As the impact of COVID-19 intensifies globally, governments and healthcare systems come under extraordinary pressure. And healthcare professionals are holding the front line to save lives…

While we are waiting for the MDR amendment to be discussed and agreed upon by the European Parliament and the Council hopefully before end May through an accelerated co-decision procedure lets try and sum up what it could mean for manufacturers of medical devices (note: As for the In Vitro Diagnostics Regulation (IVDR), which will be applicable from 26 May…